Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://gretaylny259210.blog5.net/87735626/retaglutide-a-promising-glp-1-receptor-agonist